• 2014.10.31

    During today’s Cabinet meeting, the Cabinet approved the appointment, effective today, of Dr. Makoto Suematsu, Dean of the School of Medicine, Keio University, as the president of the Japan Agency for Medical Research and Development (AMED), an independent administrative agency to be launched on April 1, 2015.
  • 2014.10.30

    Japan Tissue Engineering Co.,Ltd(J-TEC) to Become a Consolidated Subsidiary of Fujifilm Holdings
    Accelerating development and promoting commercialization of regenerative medicine products
  • 2014.10.21

    UCL research helps paralysed man to recover function
  • 2014.10.19

    Lab-developed intestinal organoids form mature human tissue in mice
    Study produces unprecedented model to study intestinal diseases
  • 2014.10.18

    HKU confers an honorary degree upon Professor Shinya Yamanaka
  • 2014.10.17

    ACT Reports the Publication of Research on the Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells (iPSC)
  • 2014.10.14

    ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells for the Treatment of Macular Degeneration
  • 2014.10.14

    Success in the development of the ultra small equipment for the culturing of human iPS cells from a single cell  - Aiming for the development of a device to support regenerative medicine-
  • 2014.10.09

    Nissan Chemical Industries, Ltd. announces that, in October this year, it began sales of the FCeM®Series, a newly developed three-dimensional culture for cancer cells, through its distributor Wako Pure Chemical Industries, Ltd. (President & CEO: Shinzo Kobatake, Head Office: in Chuo-ku, Osaka).
  • 2014.10.05

    Minister Shunichi Yamaguchi, Minister of State for Science and Technology Policy, visited Kyoto University on October 5 for discussions with university president Juichi Yamagiwa, who assumed duties on October 1. Minister Yamaguchi also took the opportunity to pay a visit to the university’s Center for iPS Cell Research and Application (CiRA).
  • 2014.10.03

    ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.
  • 2014.10.01

    Tokyo Electron Launches its Open Innovation Stem Cell Technology Centre (STC) in the UK to Develop Smart Cell Processing Technologies


See more

Page top



  • MEXT
  • Japan Science and Technology Agency
Page top